Sebetralstat (KVD900): A Potent and Selective Small Molecule Plasma Kallikrein Inhibitor Featuring a Novel P1 Group as a Potential On-demand Treatment for Hereditary Angioedema

 

YOU ARE NOW LEAVING KALVISTA.COM

You are now being directed to another KalVista website that contains information about specific treatment(s)

PROCEED TO SITE >>> Cancel